Qube Research & Technologies LTD Neurocrine Biosciences Inc Transaction History

Qube Research & Technologies LTD

$65.7 Billion
Q3 2024

A detailed history of Qube Research & Technologies LTD transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 763,355 shares of NBIX stock, worth $103 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

763,355

Previous 601,720 26.86%

Holding current value

$103 Million

Previous $82.8 Million 6.09%

% of portfolio

0.13%

Previous 0.13%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$114.58 - $153.15 $18.5 Million - $24.8 Million	161,635 Added 26.86%	763,355 $87.9 Million
Q2 2024 Aug 14, 2024	BUY	$130.86 - $143.19 $45.8 Million - $50.1 Million	349,889 Added 138.94%	601,720 $82.8 Million
Q1 2024 May 14, 2024	BUY	$130.4 - $143.74 $10.7 Million - $11.8 Million	82,221 Added 48.48%	251,831 $34.7 Million
Q4 2023 Feb 13, 2024	BUY	$106.07 - $132.76 $3.59 Million - $4.49 Million	33,840 Added 24.92%	169,610 $22.3 Million
Q3 2023 Nov 13, 2023	SELL	$94.02 - $117.1 $8.72 Million - $10.9 Million	-92,695 Reduced 40.57%	135,770 $15.3 Million
Q2 2023 Aug 14, 2023	SELL	$89.53 - $104.87 $6.61 Million - $7.74 Million	-73,798 Reduced 24.42%	228,465 $21.5 Million
Q1 2023 May 15, 2023	BUY	$94.11 - $123.02 $7.48 Million - $9.77 Million	79,446 Added 35.66%	302,263 $30.6 Million
Q4 2022 Feb 14, 2023	BUY	$106.72 - $127.06 $22.9 Million - $27.3 Million	214,655 Added 2629.93%	222,817 $26.6 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $751,148 - $879,945	8,162 New	8,162 $867,000
Q1 2022 May 09, 2022	SELL	$72.45 - $94.81 $5.13 Million - $6.71 Million	-70,739 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$79.65 - $106.22 $5.63 Million - $7.51 Million	70,739 New	70,739 $6.03 Million
Q3 2021 Nov 12, 2021	SELL	$86.18 - $99.03 $3.89 Million - $4.46 Million	-45,085 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$89.43 - $102.27 $4.03 Million - $4.61 Million	45,085 New	45,085 $4.39 Million
Q1 2021 May 14, 2021	SELL	$87.57 - $119.4 $4.21 Million - $5.74 Million	-48,046 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$86.91 - $108.33 $9.46 Million - $11.8 Million	-108,902 Reduced 69.39%	48,046 $4.61 Million
Q3 2020 Nov 12, 2020	BUY	$96.16 - $135.15 $11.6 Million - $16.4 Million	121,096 Added 337.77%	156,948 $15.1 Million
Q2 2020 Aug 14, 2020	BUY	$85.09 - $130.36 $2.49 Million - $3.81 Million	29,224 Added 440.92%	35,852 $4.37 Million
Q1 2020 May 15, 2020	SELL	$75.11 - $113.76 $250,266 - $379,048	-3,332 Reduced 33.45%	6,628 $574,000
Q4 2019 Feb 13, 2020	BUY	$86.8 - $118.57 $864,528 - $1.18 Million	9,960 New	9,960 $1.07 Million

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Neurocrine Biosciences Inc Transaction History